Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control
Viruses · 2024
DOI: 10.3390/v16091357 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Philip E Castle. Beteiligte Einrichtung: Divisions of Cancer Prevention and Cancer Epidemiology and Genetics, US National Cancer Institute, National Institutes of Health, 9609 Medical Center…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Global Health, Papillomavirus Vaccines. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 352 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. National Cancer Institute.
Abstract (Originalsprache)
Despite the introduction of Pap testing for screening to prevent cervical cancer in the mid-20th century, cervical cancer remains a common cause of cancer-related mortality and morbidity globally. This is primarily due to differences in access to screening and care between low-income and high-income resource settings, resulting in cervical cancer being one of the cancers with the greatest health disparity. The discovery of human papillomavirus (HPV) as the near-obligate viral cause of cervical cancer can revolutionize how it can be prevented: HPV vaccination against infection for prophylaxis and HPV testing-based screening for the detection and treatment of cervical pre-cancers for interception. As a result of this progress, the World Health Organization has championed the elimination of cervical cancer as a global health problem. However, unless research, investments, and actions are taken to ensure equitable global access to these highly effective preventive interventions, there is a real threat to exacerbating the current health inequities in cervical cancer. In this review, the progress to date and the challenges and opportunities for fulfilling the potential of HPV-targeted prevention for global cervical cancer control are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divisions of Cancer Prevention and Cancer Epidemiology and Genetics, US National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr., Room 5E410, Rockville, MD 20850, USA.
ORCID-Profile: Philip E Castle
Förderung
- U.S. National Cancer Institute
Zitieren
APA
Castle, P. E. (2024). Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control. Viruses. https://doi.org/10.3390/v16091357
Vancouver
Castle PE. Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control. Viruses. 2024. doi:10.3390/v16091357
BibTeX
@article{Castle2024,
author = {Castle, Philip E},
title = {Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091357}
}
EUVIMED